Browse Topic
Research
-
September 28, 2022CDC grant to study risks of combined use of opioids and ‘benzos’
UC Davis Health researchers received a $1.05 million grant from the Centers for Disease Control and Prevention to identify risk and protective factors linked to the combined use of opioids and benzodiazepines, a group of drugs used to treat anxiety and insomnia.
Read More -
September 23, 2022Uncovering the skin’s secrets: Studies show how skin forms differently across the body
Two recent UC Davis studies reveal how skin forms differently across different areas of the body from the face and underarms to the palms of our hands and feet. By profiling the changes in skin, researchers found that the differences have a direct impact for how various skin diseases form across the body.
Read More -
September 22, 2022Breaking the loop leading to muscular fibrosis
When an injury doesn’t heal correctly, fibrosis and scar tissue form in the muscles. A UC Davis team may have unlocked a way to prevent muscular fibrosis by preventing stem cells from getting stuck in an endless loop of collagen production.
Read More -
September 21, 2022UC Davis researchers explore new angle on pancreatic islet function
UC Davis researchers have shown for the first time that the signaling protein 14-3-3-zeta can shift pancreatic alpha cells from producing glucagon, which increases blood glucose, to make the antidiabetic hormone GLP-1. These findings could lead to new therapies for people with type 2 diabetes.
Read More -
September 21, 2022
Could monoclonal antibodies replace opioids for chronic pain?
During the pandemic, physicians used infusions of monoclonal antibodies to help patients fight off COVID-19 infections. Now, in response to the U.S. opioid crisis, researchers at UC Davis are trying to create monoclonal antibodies that can help fight chronic pain.
Read More -
September 13, 2022$4 million donation from Daryl Geweke supports glaucoma research and treatment
The Eye Center at UC Davis Health has two new endowed chairs focused on glaucoma research and treatment, thanks to a $4 million donation from business entrepreneur Daryl Geweke. James D. Brandt and Nicholas R. Marsh-Armstrong are the inaugural holders of the new endowed chairs.
Read More -
September 08, 2022UC Davis Health recruiting for study on using both implant, birth control pills
Are two birth control methods better than one? UC Davis Health is one of three centers in the United States, investigating if patients are willing to use both a birth control pill and a hormonal birth control implant at the same time.
Read More -
September 06, 2022New study finds racial and ethnic differences in perception and use of ‘red flag’ laws
Although extreme risk protection orders (ERPOs) show promise in preventing firearm violence, new research from the Violence Prevention Research Program finds racial and ethnic differences in how ERPOs are perceived and used in California.
Read More -
September 01, 2022Pilot grants fund research into opioid use, ADHD, firearm suicide prevention
The Behavioral Health Center of Excellence at UC Davis has awarded six pilot grants to advance mental health research. The program aims to improve mental health in California by investing in research on critical issues facing society.
Read More
-
August 31, 2022High folic acid associated with higher rates of COVID-19 infections and mortality
A new study that looked at health data from the UK found people with a folic acid prescription were 1.5 times as likely to get COVID-19 and were more than 2.6 times as likely to die from COVID-19 compared to the control group.
Read More -
August 31, 2022New study aims to identify ethnicity-specific markers for non-alcoholic fatty liver disease
Researchers have performed a first-of-its-kind study to better understand why non-alcoholic fatty liver disease affects certain races or ethnicities disproportionately. Initial findings suggest ethnicity-specific lipidomic signatures may characterize and explain the progression of the disease for certain races.
Read More -
August 30, 2022Novel study investigates cell therapy to treat swallowing disorders
This therapy could be a potential game-changer for our patients who suffer from difficulty swallowing, many of whom are cancer survivors living with the consequences of radiation toxicity.”
Read More -
August 26, 2022UC Davis Health study reports on the safety, efficacy of tecovirimat in treating monkeypox
UC Davis Health has published one of the earliest studies assessing the use of tecovirimat to treat monkeypox symptoms and skin lesions. The antiviral drug approved for smallpox treatment appeared to be safe and effective in 25 patients with monkeypox.
Read More -
August 24, 2022California Department of Public Health awards UC Davis $15.7M to manage Cancer Registry
The California Department of Public Health has awarded UC Davis Health a $15.7 million grant to co-manage California Cancer Registry. The registry is a valuable resource for cancer researchers, health policymakers and the public. It has detailed information on nearly 6 million cancer cases in California.
Read More -
August 22, 2022Surgery resident awarded prestigious T32 federal research grant
Cardiothoracic surgery resident Nataliya Bahatyrevich has become the latest UC Davis trainee to receive a prestigious T32 federal research grant. The award will allow her to spend a year in the laboratory and pursue a Master of Science in biomedical engineering at UC Davis
Read More -
August 18, 2022Clinical trial aims to develop new methods to restore speech with brain-computer interface
UC Davis Health is recruiting people for a clinical trial, BrainGate2, with the goal of building a “neurological prosthesis” for restoring speech to people who have lost — or are losing — the ability to speak due to injuries like stroke or diseases like ALS.
Read More -
August 17, 2022UC Davis launches a science academy for youth in underserved communities to study health
The UC Davis CTSC and community partner Urban Advocates and Achievers are offering the Youth Community Scientist Academy in Health Research, a 10-week educational program for high school-age students in the Oak Park, Del Paso Heights, and other Promise Zone neighborhoods of Sacramento. Registration is now open.
Read More -
August 10, 2022Researchers awarded $1.4 million to develop gene therapy for rare genetic condition
UC Davis MIND Institute researchers have been awarded $1.4 million to study the rare genetic condition CDKL5 Deficiency Disorder. The funding comes from the California Institute for Regenerative Medicine. The team will work to develop gene therapies for the condition.
Read More -
August 10, 2022Prestigious NIH grant helps UC Davis train researchers in drug discovery and development
The Department of Pharmacology has received a renewal of the prestigious NIH T32 training program grant. The funding will help educate the next generation of biomedical researchers in the concepts of drug discovery and development, inclusive of a clinical perspective.
Read More -
August 09, 2022Interdisciplinary team receives grant to improve rapid diagnostics
An interdisciplinary team has been awarded a five-year, $5.9M grant from the NIH for its work on innovative, non-intrusive diagnostic technology that aims to shorten the time it takes to diagnose a range of diseases from asthma to autism.
Read More